Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression
Cellular Oncology · 2023-06 · 46 (3) · 481-501
DOI: 10.1007/s13402-023-00770-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 23.01.2023. Verfasst von Michelle de-Souza-Ferreira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Oncobiology Program, Cancer Glycobiology Group, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, Rio de…. Hauptthemen laut MEDLINE: Acetylglucosamine, Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Changes in protein glycosylation are widely observed in tumor cells. N-glycan branching through adding β1,6-linked N-acetylglucosamine (β1,6-GlcNAc) to an α1,6-linked mannose, which is catalyzed by the N-acetylglucosaminyltransferase V (MGAT5 or GnT-V), is one of the most frequently observed tumor-associated glycan structure formed. Increased levels of this branching structure play a pro-tumoral role in various ways, for example, through the stabilization of growth factor receptors, the destabilization of intercellular adhesion, or the acquisition of a migratory phenotype. CONCLUSION: In this review, we provide an updated and comprehensive summary of the physiological and pathophysiological roles of MGAT5 and β1,6-GlcNAc branched N-glycans, including their regulatory mechanisms. Specific emphasis is given to the role of MGAT5 and β1,6-GlcNAc branched N-glycans in cellular mechanisms that contribute to the development and progression of solid tumors. We also provide insight into possible future clinical implications, such as the use of MGAT5 as a prognostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Oncobiology Program, Cancer Glycobiology Group, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, Rio de Janeiro, RJ, 20231-050, Brazil.
- Cellular and Molecular Oncobiology Program, Cancer Glycobiology Group, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, Rio de Janeiro, RJ, 20231-050, Brazil. jcjunior@inca.gov.br.
Zitieren
APA
de-Souza-Ferreira, M., Ferreira, É. E., & de-Freitas-Junior, J. C. M. (2023). Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression. Cellular Oncology, 46(3), 481-501. https://doi.org/10.1007/s13402-023-00770-4
Vancouver
de-Souza-Ferreira M, Ferreira ÉE, de-Freitas-Junior JCM. Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression. Cellular Oncology. 2023;46(3):481-501. doi:10.1007/s13402-023-00770-4
BibTeX
@article{deSouzaFerreira2023,
author = {de-Souza-Ferreira, Michelle and Ferreira, Érika Elias and de-Freitas-Junior, Julio Cesar Madureira},
title = {Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression},
journal = {Cellular Oncology},
year = {2023},
volume = {46},
number = {3},
pages = {481--501},
doi = {10.1007/s13402-023-00770-4}
}
EUVIMED